Form 4 for ABT Abbott Laboratories
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001415889-21-005270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-15 | ABT | Ahlberg Gregory A | SVP | S - Sale+OE | $130.00 | -25.5K | 15.9K | -62% | -$3.31M |
| DM | 2021-11-17 | 2021-11-15 | ABT | Ahlberg Gregory A | SVP | M - OptEx | $58.16 | +36.9K | 19.8K | New | +$2.15M |
| DM | 2021-11-17 | 2021-11-15 | ABT | Ahlberg Gregory A | SVP | M - OptEx | $0.00 | -36.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-11-15 | S | D | 21,568 | $130.00 | 25,287 | D | — | — | |
| 2 | Common | Common shares without par value | 2021-11-15 | M | A | 30,935 | $59.94 | 46,855 | D | — | — | |
| 3 | Common | Common shares without par value | 2021-11-15 | M | A | 6,000 | $48.98 | 19,825 | D | — | — | |
| 4 | Common | Common shares without par value | 2021-11-15 | S | D | 3,905 | $130.00 | 15,920 | D | — | — | |
| 5 | Derivative | Option (right to buy) | 2021-11-15 | M | D | 30,935 | $0.00 | 15,468 | D | $59.94 · 2021-02-16 to 2028-02-15 | 30,935 Common Shares | (F2) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |
| 6 | Derivative | Option (right to buy) | 2021-11-15 | M | D | 6,000 | $0.00 | 0 | D | $48.98 · 2020-08-14 to 2027-08-13 | 6,000 Common Shares | (F2) Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |